Aura Biosciences, Inc. SEC filings AURA
Aura Biosciences, Inc. has 381 filings in SEC EDGAR's recent list, going back to Sep 21, 2010. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations, exit or restructuring costs, officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Sep 1, 2026 | — |
| S-3 | Shelf registration | Aug 11, 2026 | — |
| S-8 | Employee stock plan registration | May 19, 2026 | — |
| 424B5 | Prospectus supplement | May 5, 2026 | — |
| S-3MEF | Filing | May 4, 2026 | — |
| 424B5 | Prospectus supplement | May 4, 2026 | — |
| S-8 | Employee stock plan registration | Mar 30, 2026 | — |
| 424B5 | Prospectus supplement | May 16, 2025 | — |
| 424B5 | Prospectus supplement | May 15, 2025 | — |
| S-8 | Employee stock plan registration | Mar 24, 2025 | — |
| S-3 | Shelf registration | Mar 27, 2024 | — |
| S-8 | Employee stock plan registration | Mar 27, 2024 | — |
| 424B5 | Prospectus supplement | Nov 7, 2023 | — |
| 424B5 | Prospectus supplement | Nov 6, 2023 | — |
| S-8 | Employee stock plan registration | Mar 15, 2023 | — |
| 424B5 | Prospectus supplement | Dec 1, 2022 | — |
| 424B5 | Prospectus supplement | Nov 30, 2022 | — |
| S-3 | Shelf registration | Nov 1, 2022 | — |
| S-8 | Employee stock plan registration | Mar 23, 2022 | — |
| 424B4 | Prospectus | Nov 1, 2021 | — |
| S-8 | Employee stock plan registration | Oct 29, 2021 | — |
| S-1MEF | Filing | Oct 28, 2021 | — |
| S-1/A | Amended registration statement | Oct 25, 2021 | — |
| S-1 | Registration statement | Oct 8, 2021 | — |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1501796
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.